A steroidal pain-management treatment used during radiation therapy for bone metastases has made good on its earlier promise, meaningfully outperforming placebo in a double-blind, randomized phase 3 trial.
Retroactively implementing ACR’s 2014 LungRADS classification criteria, an academic medical center increased the positive predictive value in a CT lung-screening cohort of more than 1,600 patients by a factor of 2.5—without driving an increase in surgeries following false negatives.
A new MRI technique being studied at Memorial Sloan Kettering Cancer Center in New York City could cut the time needed to reveal whether a tumor is responding to treatment from a matter of weeks to just a few days.
Cell-based therapies that exploit modified human cells to treat cancer have been a promising area of research, but issues remain. Specifically, the driver-less cells are difficult to target, especially in tissues deep in the body.
Researchers at Cedars-Sinai Medical Center in Los Angeles are working on a technique that could diagnose brain tumors and treat the cancer with a combination of an MRI “virtual biopsy” and nano-scale drugs.
One is a long-established option for colorectal cancer screening, the other is still fighting for Medicare coverage but has proven to be effective in clinical studies. Over the last week, the Huffington Post has hosted four experts providing their take on whether patients should seek out colonoscopy or CT colonography.